FLT3 and acute myeloid leukemia: The potency of compound 6 was further demonstrated from the induction of cell death via necrosis in FLT3-ITD mutant and FLT3-inhibitor resistant cell lines and primary blasts from acute myeloid leukemia (AML) patients.